Cancer rehabilitation can help patients before and after treatment, but it’s still not widely used.
by Cameron Walker
A study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.
A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.
Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.
A professional photographer shares advice on living in the moment after caring for his father, who had stage IV lung cancer.
A study investigates whether artificial intelligence can reduce false-positive mammograms.
The U.S. Food and Drug Administration has approved a new PARP inhibitor for BRCA-mutant breast cancer.
James P. Allison, PhD, a Fellow of the AACR Academy, won the 2018 Nobel Prize in Physiology or Medicine for his pioneering work in cancer immunotherapy.
Janet Freeman-Daily: On Lung Cancer and Blame
donate to the AACR
The AACR Cancer Progress Report 2018, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.